Research Article
Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
Figure 4
ROC analysis of different parameters. (a) ROC analysis of miRNAs including miR-365a-3p, miR-4286, miR-424-5p, miR-29b-3p, and miR-27a-3p; (b) ROC analysis of PSA, f/t PSA, age, and prostate volume; (c) ROC analysis using the microRNA panel (miR-4286, miR-27a-3p, and miR-29b-3p) combined with clinical parameters (PSA and prostate volume); (d) ROC analysis using the Logistics regression equation in the validation cohort.